首页> 美国卫生研究院文献>other >QOLP-14. PRELIMINARY EXAMINATION OF CONFIRMED GLIOMA RISK FACTORS AMONG EPENDYMOMA PATIENTS IN THE NEURO-ONCOLOGY BRANCH NATURAL HISTORY STUDY (NOB-NHS) AND RISK AND OUTCOMES STUDY (ROS)
【2h】

QOLP-14. PRELIMINARY EXAMINATION OF CONFIRMED GLIOMA RISK FACTORS AMONG EPENDYMOMA PATIENTS IN THE NEURO-ONCOLOGY BRANCH NATURAL HISTORY STUDY (NOB-NHS) AND RISK AND OUTCOMES STUDY (ROS)

机译:QOLP-14。在神经肿瘤科自然史研究(NOB-NHS)和风险与结果研究(ROS)中对确诊的脑膜炎胶质瘤风险因素进行初步检查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUNDThe Glioma International Case-Control (GICC) study is the largest study to date examining genetic and environmental risk factors for adult gliomas. Inverse associations have been repeatedly confirmed for allergies, atopic skin diseases, and viral infections. Evaluations of these risk factors specifically ependymoma has not been completed, due to the rarity compared to other glioma types. Therefore, the purpose of this report is evaluating the associations of these confirmed glioma risk factors with ependymomas.
机译:背景胶质瘤国际病例对照研究(GICC)是迄今为止最大的研究,研究成人胶质瘤的遗传和环境危险因素。过敏,过敏性皮肤病和病毒感染已被反复证实是反向关联。由于与其他神经胶质瘤类型相比非常罕见,因此尚未完成对这些危险因素特别是室管膜瘤的评估。因此,本报告的目的是评估这些确诊的神经胶质瘤危险因素与室间隔瘤的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号